Loading... Please wait...
MediVas Announces Signing of Collaboration Agreement with Pfizer

By combining the fully biodegradable and biocompatible MediVas polymers with the Pfizer compounds, MediVas and Pfizer hope to create a product that can change the paradigm of how ophthalmic treatments are administered. Financial terms of the agreement were not disclosed.

Click here to read the full article




Bookmark this page!
Digg!Del.icio.us!Google!Yahoo!Free social bookmarking plugins and extensions for Joomla! websites! title=
 

 

 

© 2007 CTC Clean Tech Consulting GmbH, Lindenallee 39, 20259 Hamburg, Germany
bioplastics24.com, the information and market portal for the international bioplastics industry
Joomla Templates by JoomlaShack Joomla Templates by Compass Design